These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8959996)

  • 1. A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II.
    Lacomblez L; Bensimon G; Leigh PN; Guillet P; Powe L; Durrleman S; Delumeau JC; Meininger V
    Neurology; 1996 Dec; 47(6 Suppl 4):S242-50. PubMed ID: 8959996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.
    Lacomblez L; Bensimon G; Leigh PN; Guillet P; Meininger V
    Lancet; 1996 May; 347(9013):1425-31. PubMed ID: 8676624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.
    Bensimon G; Lacomblez L; Meininger V
    N Engl J Med; 1994 Mar; 330(9):585-91. PubMed ID: 8302340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.
    Graf M; Ecker D; Horowski R; Kramer B; Riederer P; Gerlach M; Hager C; Ludolph AC; Becker G; Osterhage J; Jost WH; Schrank B; Stein C; Kostopulos P; Lubik S; Wekwerth K; Dengler R; Troeger M; Wuerz A; Hoge A; Schrader C; Schimke N; Krampfl K; Petri S; Zierz S; Eger K; Neudecker S; Traufeller K; Sievert M; Neundörfer B; Hecht M;
    J Neural Transm (Vienna); 2005 May; 112(5):649-60. PubMed ID: 15517433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study.
    Fang T; Al Khleifat A; Meurgey JH; Jones A; Leigh PN; Bensimon G; Al-Chalabi A
    Lancet Neurol; 2018 May; 17(5):416-422. PubMed ID: 29525492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riluzole and ALS therapy.
    Hugon J
    Wien Med Wochenschr; 1996; 146(9-10):185-7. PubMed ID: 8873431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis.
    Bryson HM; Fulton B; Benfield P
    Drugs; 1996 Oct; 52(4):549-63. PubMed ID: 8891467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Moore DH
    Cochrane Database Syst Rev; 2000; (2):CD001447. PubMed ID: 10796796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Moore DH
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD001447. PubMed ID: 22419278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Moore DH
    Cochrane Database Syst Rev; 2001; (4):CD001447. PubMed ID: 11687111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
    Aggarwal SP; Zinman L; Simpson E; McKinley J; Jackson KE; Pinto H; Kaufman P; Conwit RA; Schoenfeld D; Shefner J; Cudkowicz M;
    Lancet Neurol; 2010 May; 9(5):481-8. PubMed ID: 20363190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole for the treatment of amyotrophic lateral sclerosis.
    Saitoh Y; Takahashi Y
    Neurodegener Dis Manag; 2020 Dec; 10(6):343-355. PubMed ID: 32847483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Riluzole Early Access Programme: descriptive analysis of 844 patients in France. ALS/Riluzole Study Group III.
    Meininger V; Dib M; Aubin F; Jourdain G; Zeisser P
    J Neurol; 1997 May; 244 Suppl 2():S22-5. PubMed ID: 9178167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2007 Jan; (1):CD001447. PubMed ID: 17253460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole.
    Riviere M; Meininger V; Zeisser P; Munsat T
    Arch Neurol; 1998 Apr; 55(4):526-8. PubMed ID: 9561981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riluzole for amyotrophic lateral sclerosis.
    Med Lett Drugs Ther; 1995 Dec; 37(963):113-4. PubMed ID: 7500908
    [No Abstract]   [Full Text] [Related]  

  • 19. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
    Meininger V; Asselain B; Guillet P; Leigh PN; Ludolph A; Lacomblez L; Robberecht W;
    Neurology; 2006 Jan; 66(1):88-92. PubMed ID: 16401852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole does not have an acute effect on motor thresholds and the intracortical excitability in amyotrophic lateral sclerosis.
    Sommer M; Tergau F; Wischer S; Reimers CD; Beuche W; Paulus W
    J Neurol; 1999 Nov; 246 Suppl 3():III22-6. PubMed ID: 10631657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.